Skip to main content
Top
Published in: BMC Pediatrics 1/2020

Open Access 01-12-2020 | Acute Lymphoblastic Leukemia | Case report

Concurrent diabetic ketoacidosis and pancreatitis in Paediatric acute lymphoblastic leukemia receiving L-asparaginase

Authors: Patel Zeeshan Jameel, Sham Lohiya, Amol Dongre, Sachin Damke, Bhavana B. Lakhkar

Published in: BMC Pediatrics | Issue 1/2020

Login to get access

Abstract

Background

Although hyperglycemia and pancreatitis are known side effects of L-asparaginase, both contributing to the development of diabetic ketoacidosis (DKA) is unfamiliar in literature.

Case presentation

We report a case of an adolescent girl, recently diagnosed with ALL, who presented with pain in abdomen and breathing difficulty following chemotherapy with L-asparaginase. On subsequent evaluation, she was found to have high anion gap metabolic acidosis, hyperglycemia and ketonuria. Ultrasonogram showed bulky pancreas. DKA was managed with fluid correction and insulin infusion. Pancreatitis was managed conservatively. She recovered completely with resolution of symptoms and without any major adverse events despite having such severe complications.

Conclusion

We conclude that the combination of DKA and pancreatitis is a rare occurrence with significant morbidity and mortality. We recommend a close monitoring of blood glucose levels for hyperglycemia as well as a high index of clinical suspicion for pancreatitis in patients with ALL receiving L-asparaginase.
Literature
1.
go back to reference Friehling E, Kim Ritchey A, Tubergen DG, Bleyer A. Acute lymphoblastic luekemia. In: Kleigman RM, St Geme III JW, Blum NJ, Tasker RC, Shah SS, Wilson KM, editors. Nelson textbook of pediatrics. 21st ed. Philadelphia: Elsevier; 2019. p. 2649–53. Friehling E, Kim Ritchey A, Tubergen DG, Bleyer A. Acute lymphoblastic luekemia. In: Kleigman RM, St Geme III JW, Blum NJ, Tasker RC, Shah SS, Wilson KM, editors. Nelson textbook of pediatrics. 21st ed. Philadelphia: Elsevier; 2019. p. 2649–53.
2.
go back to reference Dhillon PK, Mathur P, Nandakumar A, Fitzmaurice C, Kumar GA, Mehrotra R, et al. The burden of cancers and their variations across the states of India: the global burden of disease study 1990–2016. Lancet Oncol. 2018;19(10):1289–306.CrossRef Dhillon PK, Mathur P, Nandakumar A, Fitzmaurice C, Kumar GA, Mehrotra R, et al. The burden of cancers and their variations across the states of India: the global burden of disease study 1990–2016. Lancet Oncol. 2018;19(10):1289–306.CrossRef
3.
go back to reference Kidd JG. Regression of transplanted lymphomas induced in vivo by means of normal Guinea pig serum. I. Course of transplanted cancers of various kinds in mice and rats given Guinea pig serum, horse serum, or rabbit serum. J Exp Med. 1953;98(6):565–82.PubMedPubMedCentralCrossRef Kidd JG. Regression of transplanted lymphomas induced in vivo by means of normal Guinea pig serum. I. Course of transplanted cancers of various kinds in mice and rats given Guinea pig serum, horse serum, or rabbit serum. J Exp Med. 1953;98(6):565–82.PubMedPubMedCentralCrossRef
4.
go back to reference Dolowy WC, Henson D, Cornet J, Sellin H. Toxic and antineoplastic effects of L-asparaginase. Study of mice with lymphoma and normal monkeys and report on a child with leukemia. Cancer. 1966;19(12):1813–9.PubMedCrossRef Dolowy WC, Henson D, Cornet J, Sellin H. Toxic and antineoplastic effects of L-asparaginase. Study of mice with lymphoma and normal monkeys and report on a child with leukemia. Cancer. 1966;19(12):1813–9.PubMedCrossRef
5.
go back to reference Hill JM, Roberts J, Loeb E, Khan A, MacLellan A, Hill RW. L-Asparaginase therapy for leukemia and other malignant neoplasms: remission in human leukemia. JAMA. 1967;202(9):882–8.PubMedCrossRef Hill JM, Roberts J, Loeb E, Khan A, MacLellan A, Hill RW. L-Asparaginase therapy for leukemia and other malignant neoplasms: remission in human leukemia. JAMA. 1967;202(9):882–8.PubMedCrossRef
6.
go back to reference Pession A, Valsecchi MG, Masera G, Kamps WA, Magyarosy E, Rizzari C, et al. Long-term results of a randomized trial on extended use of high dose l-Asparaginase for standard risk childhood acute lymphoblastic leukemia. J Clin Oncol. 2005;23(28):7161–7.PubMedCrossRef Pession A, Valsecchi MG, Masera G, Kamps WA, Magyarosy E, Rizzari C, et al. Long-term results of a randomized trial on extended use of high dose l-Asparaginase for standard risk childhood acute lymphoblastic leukemia. J Clin Oncol. 2005;23(28):7161–7.PubMedCrossRef
7.
go back to reference Sahu S, Saika S, Pai SK, Advani SH. L-asparaginase (Leunase) induced pancreatitis in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol. 1998;15(6):533–8.PubMedCrossRef Sahu S, Saika S, Pai SK, Advani SH. L-asparaginase (Leunase) induced pancreatitis in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol. 1998;15(6):533–8.PubMedCrossRef
8.
go back to reference Wellstein A, Glaccone G, Atkins M, Sausville E. Cytotoxic drugs. In: Brunton LL, Hilal-Dandan R, Knollmann BC, eds. The Pharmacological basis of therapeutics. 13th ed. New York: McGraw Hill Education; 2018. p. 1167–120. Wellstein A, Glaccone G, Atkins M, Sausville E. Cytotoxic drugs. In: Brunton LL, Hilal-Dandan R, Knollmann BC, eds. The Pharmacological basis of therapeutics. 13th ed. New York: McGraw Hill Education; 2018. p. 1167–120.
9.
go back to reference Hijiya N, van der Sluis IM. Asparaginase-associated toxicity in children with acute lymphoblastic leukemia. Leuk Lymphoma. 2016;57(4):748–57.PubMedCrossRef Hijiya N, van der Sluis IM. Asparaginase-associated toxicity in children with acute lymphoblastic leukemia. Leuk Lymphoma. 2016;57(4):748–57.PubMedCrossRef
10.
go back to reference Roberson JR, Raju S, Shelso J, Pui C-H, Howard SC. Diabetic ketoacidosis during therapy for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008;50(6):1207–12.PubMedCrossRef Roberson JR, Raju S, Shelso J, Pui C-H, Howard SC. Diabetic ketoacidosis during therapy for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008;50(6):1207–12.PubMedCrossRef
11.
go back to reference Plourde PV, Jeha S, Hijiya N, Keller FG, Silverman LB, Rheingold SR, et al. Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trial. Pediatr Blood Cancer. 2014;61(7):1232–8.PubMedCrossRef Plourde PV, Jeha S, Hijiya N, Keller FG, Silverman LB, Rheingold SR, et al. Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trial. Pediatr Blood Cancer. 2014;61(7):1232–8.PubMedCrossRef
12.
go back to reference Pui C-H, Burghen GA, Bowman WP, Aur RJA. Risk factors for hyperglycemia in children with leukemia receiving l-asparaginase and prednisone. J Pediatr. 1981;99(1):46–50.PubMedCrossRef Pui C-H, Burghen GA, Bowman WP, Aur RJA. Risk factors for hyperglycemia in children with leukemia receiving l-asparaginase and prednisone. J Pediatr. 1981;99(1):46–50.PubMedCrossRef
13.
go back to reference Dacou-Voutetakis C, Palis J, Haidas S, Zannos-Mariolea L, Georgiopoulou P, Matsaniotis N. Abnormal glucose tolerance in children with acute leukemia. Effect of induction chemotherapy including L-asparaginase. Am J Pediatr Hematol Oncol. 1983;5(2):139–46.PubMed Dacou-Voutetakis C, Palis J, Haidas S, Zannos-Mariolea L, Georgiopoulou P, Matsaniotis N. Abnormal glucose tolerance in children with acute leukemia. Effect of induction chemotherapy including L-asparaginase. Am J Pediatr Hematol Oncol. 1983;5(2):139–46.PubMed
14.
go back to reference Tosur M, Viau-Colindres J, Astudillo M, Redondo MJ, Lyons SK. Medication-induced hyperglycemia: pediatric perspective. BMJ Open Diabetes Res Care. 2020;8(1):e000801.PubMedPubMedCentralCrossRef Tosur M, Viau-Colindres J, Astudillo M, Redondo MJ, Lyons SK. Medication-induced hyperglycemia: pediatric perspective. BMJ Open Diabetes Res Care. 2020;8(1):e000801.PubMedPubMedCentralCrossRef
15.
go back to reference Hwangbo Y, Lee EK. Acute hyperglycemia associated with anti-Cancer medication. Endocrinol Metab. 2017;32(1):23–9.CrossRef Hwangbo Y, Lee EK. Acute hyperglycemia associated with anti-Cancer medication. Endocrinol Metab. 2017;32(1):23–9.CrossRef
16.
go back to reference Khan A, Adachi M, Hill JM. Potentiation of Diabetogenic effect of L-Asparaginase by prednisolone. Horm Metab Res. 1970;2(5):275–6.PubMedCrossRef Khan A, Adachi M, Hill JM. Potentiation of Diabetogenic effect of L-Asparaginase by prednisolone. Horm Metab Res. 1970;2(5):275–6.PubMedCrossRef
17.
go back to reference Aisyi M, Andriastuti M, Kurniati N. The effect of combination of steroid and L-Asparaginase on hyperglycemia in children with acute lymphoblastic leukemia (ALL). Asian Pac J Cancer Prev. 2019;20(9):2619–24.PubMedPubMedCentralCrossRef Aisyi M, Andriastuti M, Kurniati N. The effect of combination of steroid and L-Asparaginase on hyperglycemia in children with acute lymphoblastic leukemia (ALL). Asian Pac J Cancer Prev. 2019;20(9):2619–24.PubMedPubMedCentralCrossRef
18.
go back to reference Mondal R, Nandi M, Tiwari A, Chakravorti S. Diabetic ketoacidosis with L-asparaginase therapy. Indian Pediatr. 2011;48(9):735–6.PubMed Mondal R, Nandi M, Tiwari A, Chakravorti S. Diabetic ketoacidosis with L-asparaginase therapy. Indian Pediatr. 2011;48(9):735–6.PubMed
19.
go back to reference Cetin M, Yetgin S, Kara A, Tuncer AM, Günay M, Gümrük F, et al. Hyperglycemia, ketoacidosis and other complications of L-asparaginase in children with acute lymphoblastic leukemia. J Med. 1994;25(3–4):219–29.PubMed Cetin M, Yetgin S, Kara A, Tuncer AM, Günay M, Gümrük F, et al. Hyperglycemia, ketoacidosis and other complications of L-asparaginase in children with acute lymphoblastic leukemia. J Med. 1994;25(3–4):219–29.PubMed
20.
go back to reference Baillargeon J, Langevin A-M, Mullins J, Ferry RJ, DeAngulo G, Thomas PJ, et al. Transient hyperglycemia in Hispanic children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2005;45(7):960–3.PubMedPubMedCentralCrossRef Baillargeon J, Langevin A-M, Mullins J, Ferry RJ, DeAngulo G, Thomas PJ, et al. Transient hyperglycemia in Hispanic children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2005;45(7):960–3.PubMedPubMedCentralCrossRef
22.
go back to reference Gifford G, Milliken S, Greenfield J. Diabetic ketoacidosis secondary to L-asparaginase in acute lymphoblastic leukaemia. Intern Med J. 2013;43(8):946–8.PubMedCrossRef Gifford G, Milliken S, Greenfield J. Diabetic ketoacidosis secondary to L-asparaginase in acute lymphoblastic leukaemia. Intern Med J. 2013;43(8):946–8.PubMedCrossRef
23.
go back to reference Wolthers BO, Mogensen PR, Frandsen TL, Abrahamsson J, Behrendtz M, Heyman M, et al. Insulin-dependent diabetes: a chronic complication to acute pancreatitis in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2019;66(1):e27437.PubMedCrossRef Wolthers BO, Mogensen PR, Frandsen TL, Abrahamsson J, Behrendtz M, Heyman M, et al. Insulin-dependent diabetes: a chronic complication to acute pancreatitis in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2019;66(1):e27437.PubMedCrossRef
24.
go back to reference Wolthers BO, Frandsen TL, Abrahamsson J, Albertsen BK, Helt LR, Heyman M, et al. Asparaginase-associated pancreatitis: a study on phenotype and genotype in the NOPHO ALL2008 protocol. Leukemia. 2017;31(2):325–32.PubMedCrossRef Wolthers BO, Frandsen TL, Abrahamsson J, Albertsen BK, Helt LR, Heyman M, et al. Asparaginase-associated pancreatitis: a study on phenotype and genotype in the NOPHO ALL2008 protocol. Leukemia. 2017;31(2):325–32.PubMedCrossRef
25.
26.
go back to reference Knoderer HM, Robarge J, Flockhart DA. Predicting asparaginase-associated pancreatitis. Pediatr Blood Cancer. 2007;49(5):634–9.PubMedCrossRef Knoderer HM, Robarge J, Flockhart DA. Predicting asparaginase-associated pancreatitis. Pediatr Blood Cancer. 2007;49(5):634–9.PubMedCrossRef
27.
go back to reference Treepongkaruna S, Thongpak N, Pakakasama S, Pienvichit P, Sirachainan N, Hongeng S. Acute pancreatitis in children with acute lymphoblastic leukemia after chemotherapy. J Pediatr Hematol Oncol. 2009;31(11):812.PubMedCrossRef Treepongkaruna S, Thongpak N, Pakakasama S, Pienvichit P, Sirachainan N, Hongeng S. Acute pancreatitis in children with acute lymphoblastic leukemia after chemotherapy. J Pediatr Hematol Oncol. 2009;31(11):812.PubMedCrossRef
28.
go back to reference Raja RA, Schmiegelow K, Frandsen TL. Asparaginase-associated pancreatitis in children. Br J Haematol. 2012;159(1):18–27.PubMedCrossRef Raja RA, Schmiegelow K, Frandsen TL. Asparaginase-associated pancreatitis in children. Br J Haematol. 2012;159(1):18–27.PubMedCrossRef
29.
go back to reference Wolthers BO, Frandsen TL, Patel CJ, Abaji R, Attarbaschi A, Barzilai S, et al. Trypsin-encoding PRSS1-PRSS2 variations influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group report. Haematologica. 2019;104(3):556–63.PubMedPubMedCentralCrossRef Wolthers BO, Frandsen TL, Patel CJ, Abaji R, Attarbaschi A, Barzilai S, et al. Trypsin-encoding PRSS1-PRSS2 variations influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group report. Haematologica. 2019;104(3):556–63.PubMedPubMedCentralCrossRef
30.
go back to reference Wang J, Cheng S, Hu L, Huang T, Huang Z, Hu S. Association of asparaginase-associated pancreatitis and ULK2 gene polymorphism. Int J Clin Exp Pathol. 2020;13(3):347–56.PubMedPubMedCentral Wang J, Cheng S, Hu L, Huang T, Huang Z, Hu S. Association of asparaginase-associated pancreatitis and ULK2 gene polymorphism. Int J Clin Exp Pathol. 2020;13(3):347–56.PubMedPubMedCentral
31.
go back to reference Haddad NG, Croffie JM, Eugster EA. Pancreatic enzyme elevations in children with diabetic ketoacidosis. J Pediatr. 2004;145(1):122–4.PubMedCrossRef Haddad NG, Croffie JM, Eugster EA. Pancreatic enzyme elevations in children with diabetic ketoacidosis. J Pediatr. 2004;145(1):122–4.PubMedCrossRef
32.
go back to reference Nair S, Yadav D, Pitchumoni CS. Association of diabetic ketoacidosis and acute pancreatitis: observations in 100 consecutive episodes of DKA. Am J Gastroenterol. 2000;95(10):2795–800.PubMedCrossRef Nair S, Yadav D, Pitchumoni CS. Association of diabetic ketoacidosis and acute pancreatitis: observations in 100 consecutive episodes of DKA. Am J Gastroenterol. 2000;95(10):2795–800.PubMedCrossRef
33.
go back to reference Nagai H, Henrich H, Wünsch PH, Fischbach W, Mössner J. Role of pancreatic enzymes and their substrates in autodigestion of the pancreas. In vitro studies with isolated rat pancreatic acini. Gastroenterology. 1989;96(3):838–47.PubMedCrossRef Nagai H, Henrich H, Wünsch PH, Fischbach W, Mössner J. Role of pancreatic enzymes and their substrates in autodigestion of the pancreas. In vitro studies with isolated rat pancreatic acini. Gastroenterology. 1989;96(3):838–47.PubMedCrossRef
34.
go back to reference Oparaji J-A, Rose F, Okafor D, Howard A, Turner RL, Orabi AI, et al. Risk factors for Asparaginase-associated pancreatitis: a systematic review. J Clin Gastroenterol. 2017;51(10):907–13.PubMedCrossRef Oparaji J-A, Rose F, Okafor D, Howard A, Turner RL, Orabi AI, et al. Risk factors for Asparaginase-associated pancreatitis: a systematic review. J Clin Gastroenterol. 2017;51(10):907–13.PubMedCrossRef
Metadata
Title
Concurrent diabetic ketoacidosis and pancreatitis in Paediatric acute lymphoblastic leukemia receiving L-asparaginase
Authors
Patel Zeeshan Jameel
Sham Lohiya
Amol Dongre
Sachin Damke
Bhavana B. Lakhkar
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2020
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-020-02136-3

Other articles of this Issue 1/2020

BMC Pediatrics 1/2020 Go to the issue